Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biotechnology Index NYSE ETF (NY: FBT )

166.26 +1.32 (+0.80%)
Streaming Delayed Price Updated: 2:03 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,319
Open 165.40
Bid (Size) 166.26 (5)
Ask (Size) 166.50 (1)
Prev. Close 164.94
Today's Range 164.00 - 166.76
52wk Range 137.97 - 179.67
Shares Outstanding 68,500
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval of... 
Via Benzinga
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug. 
Via Benzinga

Performance

YTD
+3.78%
+3.78%
1 Month
-2.99%
-2.99%
3 Month
-3.12%
-3.12%
6 Month
+7.39%
+7.39%
1 Year
+19.23%
+19.23%

More News

Read More
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Via Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
Via Benzinga
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
Via Benzinga
US Judge Weighs Nationwide Ban On Abortion Pills
Via Benzinga
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
Via Benzinga
Lots Of & Increasing Evidence That Stocks Are Bottoming For Now
Via Talk Markets
How do Biotechnology Funds and ETFs Perform Over Five Years?
Via Talk Markets
Biotech ETFs That Outperformed Last Week
Via Talk Markets
Biotech ETFs To Benefit From Latest Booster Update
Via Talk Markets
Exposures COVID-19
Q2 Growth 'Nothing Short Of Virtuous': Economist
Via Benzinga
Exposures COVID-19
Top-Performing Biotech ETFs of Last Week
Via Talk Markets
5 Top ETFs With Exposure To Biogen
Via Talk Markets
5 Top ETFs With Exposure To Biogen
Via Benzinga
Exposures Product Safety
Medical Miracles Inside Biotech ETFs
Via Talk Markets
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines
Via Talk Markets
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.